logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Trypanosomatid Diseases Molecular Routes To Drug Discovery Paul M Selzereds

  • SKU: BELL-4313536
Trypanosomatid Diseases Molecular Routes To Drug Discovery Paul M Selzereds
$ 31.00 $ 45.00 (-31%)

5.0

78 reviews

Trypanosomatid Diseases Molecular Routes To Drug Discovery Paul M Selzereds instant download after payment.

Publisher: Wiley-Blackwell
File Extension: PDF
File size: 19.7 MB
Pages: 555
Author: Paul M. Selzer(eds.)
ISBN: 9783527332557, 9783527670383, 3527332553, 3527670386
Language: English
Year: 2013

Product desciption

Trypanosomatid Diseases Molecular Routes To Drug Discovery Paul M Selzereds by Paul M. Selzer(eds.) 9783527332557, 9783527670383, 3527332553, 3527670386 instant download after payment.

Content:
Chapter 1 Visceral Leishmaniasis – Current Treatments and Needs (pages 1–15): Poonam Salotra, Ruchi Singh and Karin Seifert
Chapter 2 Chemotherapy of Leishmaniasis: A Veterinary Perspective (pages 17–35): Maria Jesus Corral?Caridad and Jose Maria Alunda
Chapter 3 Pharmacological Metabolomics in Trypanosomes (pages 37–56): Darren J. Creek, Isabel M. Vincent and Michael P. Barrett
Chapter 4 Drug Design and Screening by In Silico Approaches (pages 57–79): Mattia Mori and Maurizio Botta
Chapter 5 Computational Approaches and Collaborative Drug Discovery for Trypanosomal Diseases (pages 81–102): Sean Ekins and Barry A. Bunin
Chapter 6 Interaction of Leishmania Parasites with Host Cells and its Functional Consequences (pages 103–119): Uta Schurigt, Anita Masic and Heidrun Moll
Chapter 7 Function of Glycosomes in the Metabolism of Trypanosomatid Parasites and the Promise of Glycosomal Proteins as Drug Targets (pages 121–151): Melisa Gualdron?Lopez, Paul A. M. Michels, Wilfredo Quinones, Ana J. Caceres, Luisana Avilan and Juan?Luis Concepcion
Chapter 8 Glyoxalase Enzymes in Trypanosomatids (pages 153–166): Marta Sousa Silva, Antonio E. N. Ferreira, Ricardo Gomes, Ana M. Tomas, Ana Ponces Freire and Carlos Cordeiro
Chapter 9 Trypanothione?Based Redox Metabolism of Trypanosomatids (pages 167–199): Marcelo A. Comini and Prof. Dr.med. Dr.h.c. Leopold Flohe
Chapter 10 Thiol Peroxidases of Trypanosomatids (pages 201–213): Helena Castro and Ana M. Tomas
Chapter 11 Peroxynitrite as a Cytotoxic Effector Against Trypanosoma Cruzi: Oxidative Killing and Antioxidant Resistance Mechanisms (pages 215–236): Madia Trujillo, Maria Noel Alvarez, Lucia Piacenza, Martin Hugo, Gonzalo Peluffo and Rafael Radi
Chapter 12 Selenoproteome of Kinetoplastids (pages 237–242): Alexei V. Lobanov and Vadim N. Gladyshev
Chapter 13 Replication Machinery of Kinetoplast DNA (pages 243–260): Rachel Bezalel?Buch, Nurit Yaffe and Joseph Shlomai
Chapter 14 Life and Death of Trypanosoma Brucei: New Perspectives for Drug Development (pages 261–277): Torsten Barth, Jasmin Stein, Stefan Mogk, Caroline Schonfeld, Bruno K. Kubata and Michael Duszenko
Chapter 15 Rational Selection of Anti?Microbial Drug Targets: Unique or Conserved? (pages 279–296): Boris Rodenko and Harry P. de Koning
Chapter 16 Drug Targets in Trypanosomal and Leishmanial Pentose Phosphate Pathway (pages 297–313): Marcelo A. Comini, Cecilia Ortiz and Juan Jose Cazzulo
Chapter 17 GDP?Mannose: A Key Point for Target Identification and Drug Design in Kinetoplastids (pages 315–334): Sebastien Pomel and Philippe M. Loiseau
Chapter 18 Transporters in Anti?Parasitic Drug Development and Resistance (pages 335–349): Vincent Delespaux and Harry P. de Koning
Chapter 19 Peptidases in Autophagy are Therapeutic Targets for Leishmaniasis (pages 351–364): Roderick A. M. Williams
Chapter 20 Proteases of Trypanosoma brucei (pages 365–382): Dietmar Steverding
Chapter 21 Screening Approaches Towards Trypanothione Reductase (pages 383–404): Mathias Beig, Frank Oellien, R. Luise Krauth?Siegel and Prof. Dr. Paul M. Selzer
Chapter 22 Redox?Active Agents in Reactions Involving the Trypanothione/Trypanothione Reductase?based System to Fight Kinetoplastidal Parasites (pages 405–428): Thibault Gendron, Don Antoine Lanfranchi and Elisabeth Davioud?Charvet
Chapter 23 Inhibition of Trypanothione Synthetase as a Therapeutic Concept (pages 429–443): Dr. Oliver Koch, Dr. Timo Jager, Prof. Dr.med. Dr.h.c. Leopold Flohe and Prof. Dr. Paul M. Selzer
Chapter 24 Targeting the Trypanosomatidic Enzymes Pteridine Reductase and Dihydrofolate Reductase (pages 445–472): Stefania Ferrari, Valeria Losasso, Puneet Saxena and Maria Paola Costi
Chapter 25 Contribution to New Therapies for Chagas Disease (pages 473–487): Patricia S. Doyle and Juan C. Engel
Chapter 26 Ergosterol Biosynthesis for the Specific Treatment of Chagas Disease: From Basic Science to Clinical Trials (pages 489–514): Julio A. Urbina
Chapter 27 New Developments in the Treatment of Late?Stage Human African Trypanosomiasis (pages 515–529): Cyrus J. Bacchi, Robert T. Jacobs and Nigel Yarlett

Related Products